Ir al contenido
Georgia Commons

Código Oficial de Georgia Anotado

Título 16. CRIMES AND OFFENSES · Capítulo 12. OFFENSES AGAINST PUBLIC HEALTH AND MORALS · Artículo 9. ACCESS TO MEDICAL CANNABIS · Parte 3. DISPENSING AND DISTRIBUTION

16-12-235. Research in compliance with federal regulations.

Vigente

Actualizado hasta: Including Acts of the 2025 Regular Session of the General Assembly.

El texto siguiente es la ley tal como la imprime el estado, en inglés.

  1. Notwithstanding anything to the contrary within this article, nothing herein shall be construed to prohibit the conduct of research involving low THC oil, cannabis, or products that is conducted in full accordance with federal regulations, including the regulations of the United States Food and Drug Administration and United States Drug Enforcement Administration by any university or nonprofit institution of higher education within the State of Georgia, provided that:

  2. (1)

    The university researchers conducting the research have the appropriate federal and state permits to acquire and use low THC oil, cannabis, or products in clinical or preclinical research; and#

  3. (2)

    The substances used for such research are obtained from licensed pharmaceutical companies or through channels established by the United States government, such as the National Institute on Drug Abuse.#

Las notas siguientes se imprimen con la sección, pero no son ley promulgada (O.C.G.A. § 1-1-1(c)). Se muestran aparte del texto.

History

Code 1981, § 16-12-235, enacted by Ga. L. 2019, p. 43, § 4/HB 324; Ga. L. 2021, p. 184, § 23/SB 195; Ga. L. 2022, p. 352, § 16/HB 1428.

Amendments

The 2022 amendment, effective May 2, 2022, part of an Act to revise, modernize, and correct the Code, deleted the subsection (a) designation; and deleted former subsection (b), which read: “Nothing in this article shall be construed to prohibit research otherwise permitted by Chapter 51 of Title 31.”.

Editor's notes

Ga. L. 2021, p. 184, § 28/SB 195, not codified by the General Assembly, provides that: “Nothing in this Act shall be deemed to change, amend, or alter any criteria for applications for a Class 1 or Class 2 production license submitted to the Georgia Access to Medical Cannabis Commission on or prior to January 27, 2021.”

Leer la página oficial (el PDF del estado, abierto en la página de la que se leyó este texto).

Actualizado hasta: Including Acts of the 2025 Regular Session of the General Assembly.

Texto leído de t16-ch12-17-(v14b)-2024-pdf.pdf, Volumen V14B, edición 2024, páginas 219 a 220; acción de fusión: carried; SHA-256 del archivo 36dbab616896.